ES8800039A1 - Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso. - Google Patents

Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.

Info

Publication number
ES8800039A1
ES8800039A1 ES543401A ES543401A ES8800039A1 ES 8800039 A1 ES8800039 A1 ES 8800039A1 ES 543401 A ES543401 A ES 543401A ES 543401 A ES543401 A ES 543401A ES 8800039 A1 ES8800039 A1 ES 8800039A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
liquid
powder
silicate
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543401A
Other languages
English (en)
Spanish (es)
Other versions
ES543401A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10561403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8800039(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES543401A0 publication Critical patent/ES543401A0/es
Publication of ES8800039A1 publication Critical patent/ES8800039A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES543401A 1984-05-23 1985-05-22 Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso. Expired ES8800039A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848413191A GB8413191D0 (en) 1984-05-23 1984-05-23 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
ES543401A0 ES543401A0 (es) 1987-11-01
ES8800039A1 true ES8800039A1 (es) 1987-11-01

Family

ID=10561403

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543401A Expired ES8800039A1 (es) 1984-05-23 1985-05-22 Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.

Country Status (12)

Country Link
US (2) US4719228A (OSRAM)
EP (1) EP0163178B1 (OSRAM)
JP (1) JPH0772128B2 (OSRAM)
CA (1) CA1255222A (OSRAM)
DE (1) DE3580304D1 (OSRAM)
ES (1) ES8800039A1 (OSRAM)
GB (1) GB8413191D0 (OSRAM)
GR (1) GR851254B (OSRAM)
IE (1) IE57732B1 (OSRAM)
MX (1) MX163564B (OSRAM)
NZ (1) NZ212148A (OSRAM)
ZA (1) ZA853823B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248700A (en) * 1982-05-14 1993-09-28 Akzo Nv Active agent containing solid structures for prolonged release of active agents
JPS6245537A (ja) * 1985-08-23 1987-02-27 Sumitomo Electric Ind Ltd 医用樹脂組成物及びその製造方法
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
US5030446A (en) * 1990-01-24 1991-07-09 Revlon, Inc. Oil- and talc-free cosmetic powder composition
DK0448091T3 (da) * 1990-03-23 1999-05-03 Yoshitomi Pharmaceutical Farmaceutisk præparat indeholdende et i ringe grad vandopløseligt medikament
EP0530833B1 (en) * 1991-09-05 1996-04-17 TSUMURA & CO. Process to prepare hard gelatine capsules containing chinese herbal extracts
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE19506141A1 (de) 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
US5766668A (en) * 1995-03-27 1998-06-16 Chinook Group, Inc. Method for synthesizing chloride based feed precursor and product resulting therefrom
SE9704400D0 (sv) 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
DE19825687A1 (de) * 1998-06-09 1999-12-16 Degussa Wirkstoffkonzentrat
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
HK1040921B (en) * 1998-12-23 2005-12-30 Alza Corporation Dosage forms comprising porous particles
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
MXPA04007438A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
EP1358805A1 (en) * 2002-04-30 2003-11-05 Aventis Animal Nutrition S.A. Animal feed supplement
EP1601347A1 (en) * 2003-02-19 2005-12-07 LifeCycle Pharma A/S Use of a silica or silica derivative as a sorption material
EP1596835A1 (en) * 2003-02-19 2005-11-23 H. Lundbeck A/S Method for preparation of an agglomerate using melt agglomeration
JP2007501218A (ja) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
US20050096390A1 (en) * 2003-10-10 2005-05-05 Per Holm Compositions comprising fenofibrate and pravastatin
US7658944B2 (en) * 2003-10-10 2010-02-09 Lifecycle Pharma A/S Solid dosage form comprising a fibrate
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
WO2005034908A2 (en) * 2003-10-10 2005-04-21 Lifecycle Pharma A/S A solid dosage form comprising a fibrate and a statin
TW200528110A (en) * 2003-12-17 2005-09-01 Schering Corp Pharmaceutical compositions
EA013433B1 (ru) * 2005-02-15 2010-04-30 Элан Фарма Интернэшнл Лтд. Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
AP2986A (en) 2007-02-23 2014-09-30 Gilead Sciences Inc Modulators of pharmacokinetic properties of therapeutics
MX342377B (es) 2008-05-02 2016-09-27 Gilead Sciences Inc Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
US8535392B2 (en) * 2008-11-25 2013-09-17 Milliken & Company Solid polymeric colorant compositions
EP3745848A1 (en) 2018-01-29 2020-12-09 Spécialités Pet Food Litter for promoting pet's in-litter elimination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern

Also Published As

Publication number Publication date
GB8413191D0 (en) 1984-06-27
CA1255222A (en) 1989-06-06
IE851262L (en) 1985-11-23
JPS60258113A (ja) 1985-12-20
MX163564B (es) 1992-06-01
AU4280085A (en) 1985-11-28
EP0163178A2 (en) 1985-12-04
NZ212148A (en) 1989-01-06
IE57732B1 (en) 1993-03-24
ZA853823B (en) 1986-04-30
DE3580304D1 (de) 1990-12-06
JPH0772128B2 (ja) 1995-08-02
ES543401A0 (es) 1987-11-01
US4719228A (en) 1988-01-12
US4859709A (en) 1989-08-22
EP0163178B1 (en) 1990-10-31
GR851254B (OSRAM) 1985-11-25
EP0163178A3 (en) 1987-01-14
AU589561B2 (en) 1989-10-19

Similar Documents

Publication Publication Date Title
ES8800039A1 (es) Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.
GB2200109B (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
MXPA99009542A (OSRAM)
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
EP0177920A3 (en) Pharmaceutical composition for external use containing active type vitam d3
DE3360433D1 (en) Oxime ethers, process for their preparation, agents containing the oxime ethers and their use
IL77762A (en) 11beta-phenyl gonane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA878953B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
HUT41203A (en) Herbicide compositions containing 2-/2-comma above-substituted benzoyl/-1,3-cyclomexene-dione derivatives as active agents and process for producing the active agents
EG18379A (en) Novel pharmacological compounds
ES8500065A1 (es) Procedimiento de preparar geles ambientadores del aire
HUT41951A (en) Process for producing insecticide compositions containing fluorinated ethers as active agents and process for producing the active agents
PT76745B (en) Process for the preparation of imidazo-<1,2-c>pyrazolio-<3,4-e>-pyrimidines with antipsychotic effect and pharmaceutical compositions therewith
ZA8410057B (en) New 2-phenyl-imidazoles,the preparation thereof and pharmaceutical compositions containing these compounds
IE812643L (en) Disintegrating pressed shapes
ZA859729B (en) New imidazo derivatives,the preparation thereof and pharmaceutical compositions containing these compounds
GB2161174B (en) Process for the preparation of an absorbing and adsorbing agent, and an absorbing and adsorbing agent thus produced
DE3266360D1 (en) Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation
TW348063B (en) A pharmaceutical composition in the form of plaster containing pranoprofen
HK40995A (en) Improved pozzolanic compositions
GR80698B (en) N-cyclized benzenesulfonamides, process for the preparation thereof and their use as active substances in pharmaceutical compositons
KR870000015A (ko) 쑥차의 제조방법
IL93317A0 (en) Cell antiproliferation factor containing suppressin,processes for the preparation thereof and pharmaceutical compositions containing the same
PH16253A (en) Dibenzazepine derivatives,pharmaceutical composition containing them and use of the compound

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070811